Dr. Ayaka Nishikawa, Chief Director of Dermatology at Shonan Beauty Clinic, Presents Her Research Findings at the 89th Annual Meeting of the Japanese Dermatological Association, Tokyo Branch

Sharing Insights on the New Potential of Ultrasound Energy Devices and the Expanding Range of Treatment Options

IRVINE, Calif. -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a global provider of comprehensive consulting and management services to medical corporations and their clinics, today announced that Dr. Ayaka Nishikawa, Chief Director of Dermatology at Shonan Beauty Clinic which operates with management support from the Company presented her research findings at the 89th Annual Meeting of the Japanese Dermatological Association, Tokyo Branch, held over two days beginning Saturday, November 15, 2025.

The Japanese Dermatological Association (JDA) is Japan’s largest professional society dedicated to the advancement of dermatology and aesthetic dermatology, bringing together dermatologists and researchers from university hospitals and medical institutions nationwide. The Tokyo Branch of the JDA hosts the “Annual Meeting of the Japanese Dermatological Association, Tokyo Branch,” where the latest findings across a broad range of fields from basic research to clinical practice are shared. Dr. Ayaka Nishikawa was invited to speak at the 89th Annual Meeting in recognition of her previous conference presentations and extensive clinical achievements.

At the conference, Dr. Nishikawa presented clinical data from Shonan Beauty Clinic on skin-tightening treatments utilizing Synchronous Parallel Ultrasound Beam (SUPERBⓇ) technology. Her presentation provided an overview of the unique energy-delivery mechanism of SUPERBⓇ, key considerations in clinical practice, and insights gained from actual patient cases. She also discussed the role of ultrasound based devices in skin-tightening treatments, comparing them with conventional technologies and highlighting the increasing range of treatment options available to meet diverse patient needs. Her approach—bridging evidence accumulation with real-world clinical practice drew significant attention from attending physicians and researchers. In recent years, technological innovation in aesthetic medicine has accelerated, underscoring the growing importance of knowledge-sharing and academic collaboration beyond daily clinical care. Meeting the increasingly diverse needs of patients requires not only the adoption of cutting edge technologies but also broad perspective and adaptability. SBC Medical Group will continue to promote advanced initiatives through academic presentations and collaborations with research institutions, contributing to the sustainable development of the aesthetic medical field.

Overview of the 89th Annual Meeting of the Japanese Dermatological Association, Tokyo Branch

- Venue: Keio Plaza Hotel

- Dates: Saturday, November 15 – Sunday, November 16, 2025

-Official Website: https://jdatokyo89.jda-conv.jp/index.html

Presentation Title

Clinical Report on Skin-Tightening Treatment Using Synchronous Parallel Ultrasound Beam (SUPERBⓇ) Technology

About Dr. Ayaka Nishikawa

After graduating from the School of Medicine at Yokohama City University, Dr. Ayaka Nishikawa joined Shonan Beauty Clinic in 2015 as a dermatologist specializing in aesthetic medicine. In 2018, she was appointed Chief Director of Dermatology and currently oversees a wide range of initiatives across the SBC Medical Group, including the development of new dermatological treatments, technical training for doctors and nurses, and safety management. Through the analysis of clinical cases, she is dedicated to promoting evidence-based medical practice and actively engages in academic activities such as presenting at domestic and international conferences and contributing to medical journals. In recognition of her achievements, she was appointed Visiting Professor at SBC Tokyo Medical University in 2023. For more information on Dr. Nishikawa’s professional profile, please visit [here].

About SBC Medical Group Holdings Incorporated

SBC Medical Group Holdings Incorporated is a comprehensive medical group operating a wide range of franchise businesses across diverse medical fields, including advanced aesthetic medicine, dermatology, orthopedics, fertility treatment, dentistry, AGA (hair restoration), and ophthalmology. The Company manages a diverse portfolio of clinic brands and is actively expanding its global presence, particularly in the United States and Asia, through both direct operations and medical tourism initiatives. In September 2024, the Company was listed on Nasdaq, and in June 2025, it was selected for inclusion in the Russell 3000® Index, a broad benchmark of the U.S. equity market. Guided by its Group Purpose “Contributing to the well-being of people around the world through medical innovation,” SBC Medical Group Holdings Incorporated continues to provide safe, trusted, and high-quality medical services while further strengthening its international reputation for quality and trust in medical care.

For more information, visit https://sbc-holdings.com/

Contacts

SBC Medical Group Holdings Incorporated (Asia)

Hikaru Fukui / Head of Investor Relations E-mail: ir@sbc-holdings.com

Daisuke Murakami / Public Relations Officer E-mail: pr@sbc.or.jp

ICR LLC (In the US)

Bill Zima / Managing Partner Email: bill.zima@icrinc.com